Optum AI, Foundation Models, and Clinical GenAI Evaluation
Recent Health AI work across structured EHR and CPT sequence modeling, recommender systems, clinical GenAI evaluation, monitoring, and responsible AI review.
Healthcare is moving from isolated machine learning models toward AI systems that need to be evaluated, monitored, and trusted in real clinical workflows. My work sits in that gap: I build and evaluate Health Artificial Intelligence (Health AI) systems across clinical Generative Artificial Intelligence (GenAI), healthcare foundation models, recommender systems, structured Electronic Health Record (EHR) modeling, Current Procedural Terminology (CPT) sequence modeling, and medical imaging. In other words, I focus on turning advanced AI methods into measurable healthcare tools that can stand up to clinical, product, and governance scrutiny.
I am most interested in senior applied scientist and Health AI roles where the work combines ambiguous product discovery, rigorous model evaluation, and real healthcare impact. I am especially drawn to teams building clinical GenAI evaluation and safety systems, healthcare foundation models, structured EHR or CPT models, recommender systems for care navigation, and multimodal medical imaging products.
For recruiters and hiring teams who want more context, these internal write-ups connect the summary above to specific projects, publications, and technical perspectives.
Recent Health AI work across structured EHR and CPT sequence modeling, recommender systems, clinical GenAI evaluation, monitoring, and responsible AI review.
A practical discussion of how agentic systems can be evaluated with area under the receiver operating characteristic curve (AUC) when outputs are not naturally continuous.
Mammography-based risk prediction work focused on interval and screen-detected cancer, including clinical evaluation against established risk factors.
Dual-energy three-compartment breast imaging with artificial intelligence for compositional biomarkers and cancer detection.
Generative imaging work that predicts analyzable dual energy X-ray absorptiometry (DXA) scans from external three-dimensional body shape.
Postdoctoral work on computed tomography (CT) imaging, body-composition pipelines, natural language processing case finding, and spleen segmentation.
I design evaluation plans that connect automated metrics with clinical SME review, adversarial testing, and continuous monitoring. However, I do not treat evaluation as a dashboard exercise; the goal is to understand whether a model behaves reliably enough for the clinical workflow it is entering.
I build large-scale sequence models for structured healthcare data, including EHR and CPT modeling. In other words, I work on the less flashy but high-impact side of foundation models: learning from longitudinal healthcare events and connecting those representations to useful recommendation and planning problems.
My PhD and postdoctoral work focused on medical imaging, cancer risk prediction, quantitative biomarkers, and CT analysis. That background helps me evaluate AI work through both a technical lens and a clinical evidence lens.
I have led ambiguous discovery and testing work across clinical, product, engineering, data science, and business teams. As such, I am comfortable translating between model behavior, clinical risk, implementation constraints, and executive decision-making.
I care about Health AI that is technically strong, clinically grounded, and measured honestly. If your team is building AI systems that need to work in real healthcare settings, I would be glad to connect at leonglambert@gmail.com or through my resume.